NCT01744431View on ClinicalTrials.gov

Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Venous Thromboembolism
Trial Locations (1)

Unknown

Emek medical center, Afula

All Listed Sponsors
lead

HaEmek Medical Center, Israel

OTHER

NCT01744431 - Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients | Biotech Hunter | Biotech Hunter